# EA Pharma

EA Pharma is a Corporate Investor based in Tokyo, Japan.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Tokyo, Japan
- **Region:** Asia
- **Address:** Tokyo, Japan
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** eapharma.co.jp
- **LinkedIn:** https://www.linkedin.com/company/ea-pharma

## Regulatory record

- **Reports private funds:** No

## About

EA Pharma was established in 2016 and is headquartered in Tokyo, Japan. It was formed through the integration of gastrointestinal business units. It operates as a result of the Eisai Group and the Ajinomoto Group integration. EA Pharma maintains a strategic licensing partnership with Newron Pharmaceuticals. Motion Equity Partners holds private equity ownership of the related EA Pharma France entity. The firm supports ISPNO Family Day and Japan Children's Cancer Group initiatives. The firm lists one additional industrial office in Fukushima, Japan. No recent operational events from the last 24 months are recorded in available sources.

## Sectors

- Healthcare Services

## Offices

- Fukushima Business Office, Fukushima, Japan

## Questions

### Who are the primary owners of EA Pharma?

Eisai Co., Ltd. holds a 60 percent stake and Ajinomoto Co., Inc. holds the remaining 40 percent.

### What is EA Pharma's relationship to Motion Equity Partners?

Motion Equity Partners acts as private equity owner of the EA Pharma France entity within the Olyos Group.

### Does EA Pharma maintain any industry association memberships?

EA Pharma is a member of the Clinical Data Interchange Standards Consortium.

## Related profiles

- [Eagle Venture Fund](https://altss.com/profile/eagle-venture-fund)
- [EAP Property Services Group](https://altss.com/profile/eap-property-services-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/ea-pharma

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology